Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2)
Non-conventional
| WHO COVID | ID: covidwho-268088
ABSTRACT
The COVID-19 health crisis joined, rather than supplanted, the opioid crisis as the most acutely pressing threats to US public health. In the setting of COVID-19, opioid use disorder treatment paradigms are being disrupted, including the fact that methadone clinics are scrambling to give "take-home" doses where they would typically not. The rapid transition away from in-person examination, dosing and group therapy in an era of social isolation calls for adjustments to clinical practice, including emphasizing patient-provider communication, favoring new inductees on buprenorphine and leveraging technology to optimize safety of medication treatment.
Search on Google
Collection:
Databases of international organizations
Database:
WHO COVID
Type of study:
Prognostic study
Document Type:
Non-conventional
Similar
MEDLINE
...
LILACS
LIS